You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API sodium phenylbutyrate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing sodium phenylbutyrate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Medunik USA PHEBURANE sodium phenylbutyrate 71770-100 ETHYLCELLULOSES
Medunik USA PHEBURANE sodium phenylbutyrate 71770-100 HYPROMELLOSE 2910
Medunik USA PHEBURANE sodium phenylbutyrate 71770-100 POLYETHYLENE GLYCOL 1500
Medunik USA PHEBURANE sodium phenylbutyrate 71770-100 POVIDONE K25
Medunik USA PHEBURANE sodium phenylbutyrate 71770-100 STARCH, CORN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing sodium phenylbutyrate

Company Ingredient NDC Excipient
Sigmapharm Laboratories LLC sodium phenylbutyrate 42794-086 CALCIUM STEARATE
Sigmapharm Laboratories LLC sodium phenylbutyrate 42794-086 SILICON DIOXIDE
ENDO USA Inc sodium phenylbutyrate 49884-006 CALCIUM STEARATE
ENDO USA Inc sodium phenylbutyrate 49884-006 SILICON DIOXIDE
GLENMARK PHARMACEUTICALS INC USA sodium phenylbutyrate 68462-853 CALCIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for sodium phenylbutyrate

Excipient focus: ACACIA

Excipient focus: CALCIUM STEARATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: DEXTRATES

Excipient focus: ETHYLCELLULOSES

Excipient focus: HYPROMELLOSE 2910

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: POLYETHYLENE GLYCOL 1500

Excipient focus: POVIDONE K25

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links